vs
T1 Energy Inc.（TE）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
T1 Energy Inc.的季度营收约是再鼎医药的1.7倍（$210.5M vs $127.1M），T1 Energy Inc.自由现金流更多（$55.0M vs $-26.7M）
索尼能源设备株式会社是隶属于索尼集团设备事业部的全资子公司，是一家日本跨国企业，深耕能源产业多领域业务。该公司1975年2月在日本福岛成立，依托索尼的技术积累，在能源相关产品研发、生产及商业化方面具备行业领先实力。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
TE vs ZLAB — 直观对比
营收规模更大
TE
是对方的1.7倍
$127.1M
自由现金流更多
TE
多$81.7M
$-26.7M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $210.5M | $127.1M |
| 净利润 | $-130.6M | — |
| 毛利率 | 10.0% | 51.0% |
| 营业利润率 | -45.0% | -54.6% |
| 净利率 | -62.0% | — |
| 营收同比 | — | 17.1% |
| 净利润同比 | -375.2% | — |
| 每股收益（稀释后） | $-0.87 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TEZLAB
| Q4 25 | — | $127.1M | ||
| Q3 25 | $210.5M | $115.4M | ||
| Q2 25 | $132.8M | $109.1M | ||
| Q1 25 | $53.5M | $105.7M | ||
| Q4 24 | — | $108.5M | ||
| Q3 24 | $0 | $101.8M | ||
| Q2 24 | $0 | $100.1M | ||
| Q1 24 | $0 | $87.1M |
净利润TEZLAB
| Q4 25 | — | — | ||
| Q3 25 | $-130.6M | $-36.0M | ||
| Q2 25 | $-31.9M | $-40.7M | ||
| Q1 25 | $-16.2M | $-48.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-27.5M | $-41.7M | ||
| Q2 24 | $-27.0M | $-80.3M | ||
| Q1 24 | $-28.5M | $-53.5M |
毛利率TEZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | 10.0% | 59.5% | ||
| Q2 25 | 24.7% | 60.6% | ||
| Q1 25 | 33.3% | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率TEZLAB
| Q4 25 | — | -54.6% | ||
| Q3 25 | -45.0% | -42.3% | ||
| Q2 25 | -22.0% | -50.3% | ||
| Q1 25 | -44.2% | -53.3% | ||
| Q4 24 | — | -62.6% | ||
| Q3 24 | — | -66.6% | ||
| Q2 24 | — | -76.0% | ||
| Q1 24 | — | -80.7% |
净利率TEZLAB
| Q4 25 | — | — | ||
| Q3 25 | -62.0% | -31.2% | ||
| Q2 25 | -24.0% | -37.3% | ||
| Q1 25 | -30.4% | -45.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -40.9% | ||
| Q2 24 | — | -80.2% | ||
| Q1 24 | — | -61.4% |
每股收益（稀释后）TEZLAB
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $-0.87 | $-0.03 | ||
| Q2 25 | $-0.21 | $-0.04 | ||
| Q1 25 | $-0.11 | $-0.04 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | $-0.20 | $-0.04 | ||
| Q2 24 | $-0.19 | $-0.08 | ||
| Q1 24 | $-0.20 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.1M | $689.6M |
| 总债务越低越好 | $547.3M | — |
| 股东权益账面价值 | $96.9M | $715.5M |
| 总资产 | $1.4B | $1.2B |
| 负债/权益比越低杠杆越低 | 5.65× | — |
8季度趋势，按日历期对齐
现金及短期投资TEZLAB
| Q4 25 | — | $689.6M | ||
| Q3 25 | $34.1M | $717.2M | ||
| Q2 25 | $8.5M | $732.2M | ||
| Q1 25 | $48.9M | $757.3M | ||
| Q4 24 | — | $779.7M | ||
| Q3 24 | $181.9M | $616.1M | ||
| Q2 24 | $219.6M | $630.0M | ||
| Q1 24 | $249.9M | $650.8M |
总债务TEZLAB
| Q4 25 | — | — | ||
| Q3 25 | $547.3M | — | ||
| Q2 25 | $591.2M | — | ||
| Q1 25 | $603.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $602.3M | — |
股东权益TEZLAB
| Q4 25 | — | $715.5M | ||
| Q3 25 | $96.9M | $759.9M | ||
| Q2 25 | $183.9M | $791.7M | ||
| Q1 25 | $201.9M | $810.8M | ||
| Q4 24 | — | $840.9M | ||
| Q3 24 | $538.7M | $667.7M | ||
| Q2 24 | $561.6M | $704.2M | ||
| Q1 24 | $582.3M | $762.2M |
总资产TEZLAB
| Q4 25 | — | $1.2B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $615.0M | $985.3M | ||
| Q2 24 | $644.4M | $987.4M | ||
| Q1 24 | $670.3M | $988.4M |
负债/权益比TEZLAB
| Q4 25 | — | — | ||
| Q3 25 | 5.65× | — | ||
| Q2 25 | 3.21× | — | ||
| Q1 25 | 2.99× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.03× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.9M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $55.0M | $-26.7M |
| 自由现金流率自由现金流/营收 | 26.1% | -21.0% |
| 资本支出强度资本支出/营收 | 4.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-42.3M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流TEZLAB
| Q4 25 | — | $-26.0M | ||
| Q3 25 | $63.9M | $-32.0M | ||
| Q2 25 | $33.4M | $-31.0M | ||
| Q1 25 | $-44.8M | $-61.7M | ||
| Q4 24 | — | $-55.8M | ||
| Q3 24 | $-28.4M | $-26.8M | ||
| Q2 24 | $-28.0M | $-42.2M | ||
| Q1 24 | $-16.2M | $-90.1M |
自由现金流TEZLAB
| Q4 25 | — | $-26.7M | ||
| Q3 25 | $55.0M | $-35.0M | ||
| Q2 25 | $10.6M | $-33.9M | ||
| Q1 25 | $-74.0M | $-63.2M | ||
| Q4 24 | — | $-58.4M | ||
| Q3 24 | $-34.0M | $-28.2M | ||
| Q2 24 | $-35.6M | $-42.9M | ||
| Q1 24 | $-37.7M | $-91.1M |
自由现金流率TEZLAB
| Q4 25 | — | -21.0% | ||
| Q3 25 | 26.1% | -30.4% | ||
| Q2 25 | 8.0% | -31.1% | ||
| Q1 25 | -138.4% | -59.9% | ||
| Q4 24 | — | -53.8% | ||
| Q3 24 | — | -27.7% | ||
| Q2 24 | — | -42.9% | ||
| Q1 24 | — | -104.5% |
资本支出强度TEZLAB
| Q4 25 | — | 0.5% | ||
| Q3 25 | 4.2% | 2.6% | ||
| Q2 25 | 17.2% | 2.6% | ||
| Q1 25 | 54.5% | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TE
| Related Party | $120.1M | 57% |
| Nonrelated Party | $90.4M | 43% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
